New York, NY -- (SBWIRE) -- 01/27/2014 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today We bring special trend analysis of following stocks: Align Technology, Inc. (NASDAQ:ALGN), Hexcel Corporation (NYSE:HXL), WuXi PharmaTech (Cayman) Inc. (ADR)(NYSE:WX), Celldex Therapeutics, Inc. (NASDAQ:CLDX)
PLUS you’ll get KingPennyStock’s Pro Trading Rules Mini E-book absolutely FREE! Claim Your Copy
Align Technology, Inc. (NASDAQ:ALGN) opened its shares at the price of $62.85 for the day. Its closing price was $58.88 after losing -7.13% for the day. The company traded with the total volume of 2.79 million shares, while its average trading volume remained 1.30 million shares. The beta of ALGN stands at2.01. Align Technology, Inc. operates as a medical device company primarily in the United States and internationally. It designs, manufactures, and markets a system of clear aligner therapy, intra-oral scanners, and computer-aided design and computer-aided manufacturing (CAD/CAM) digital services that are used in dentistry, orthodontics, and dental records storage.
Has ALGN Found The Bottom and Ready To Move Up? Find Out Here
Hexcel Corporation (NYSE:HXL) percentage change plunged -7.04% to close at $42.80 with the total traded volume of 2.25 million shares, and average volume of 588,121.00 shares. The 52 week range of the stock remained $26.46 - $46.46, while its day lowest price was $42.14 and it hit its day highest price at $45.63. Hexcel Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of lightweight and high-performance structural materials for use in commercial aerospace, space and defense, and industrial applications.
Has HXL Found The Bottom And Ready To Gain Momentum? Find Out Here
WuXi PharmaTech (Cayman) Inc. (ADR)(NYSE:WX) started its trading session with the price of $36.00 and closed at $33.73 by scoring -7.03%. WX’s stocks traded with total volume of 1.97 million shares, while the average trading volume remained 790,887.00 shares. The beta of WX stands at 1.53. Day range of the stock was $32.50 -$36.33. Wuxi PharmaTech (Cayman) Inc., through its subsidiaries, operates as a pharmaceutical, biotechnology, and medical device research and development outsourcing company in China and the United States. It operates in two segments, Laboratory Services and Manufacturing Services.
Why Should Investors Buy WX After the Recent Fall? Just Go Here and Find Out
Celldex Therapeutics, Inc. (NASDAQ:CLDX) ended its day with the loss of -6.99% and closed at the price of $27.14 after opening at $28.36. Stock traded during its last trading session with the total volume of 2.36 million shares, as compared to its average volume of 2.12 million shares. Celldex Therapeutics, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of novel therapeutics for human health care primarily in the United States.
Will CLDX Get Buyers Even After The Recent Rally? Find Out Here
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)